Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome

被引：0

作者：

L. Michaux

I. Wlodarska

I. Theate

M. Stul

J.-M. Scheiff

V. Deneys

A. Ferrant

A. Hagemeijer

机构：

[1] Cliniques universitaires UCL St Luc,Department of Hematology, Clinical Biology and Pathology

[2] University of Leuven,Center for Human Genetics

来源：

Annals of Hematology | 2004年 / 83卷

关键词：

Mantle cell lymphoma; Blastoid; CMYC;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A patient with mantle cell lymphoma (MCL) of the pleomorphic blastoid subtype is reported. The disease was clinically aggressive and refractory to chemotherapy, and the patient survived only 2 months. Cytogenetically, a t(11;19;14)(q13;q13;q32) was found. Fluorescent in situ hybridization (FISH) and molecular analyses demonstrated involvement of the BCL1/CCND1 locus in a three-way translocation. In addition, subclonal abnormalities of the region 8q24 manifested either as a t(8;22)(q24;q11)/CMYC rearrangement or trisomy 8 were identified. The pathogenetic impact of this very uncommon association of BCL1/CCND1 and CMYC rearrangements in MCL is discussed and the literature is reviewed.

引用

页码：578 / 583

页数：5

共 50 条

[1] Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome
Michaux, L
Wlodarska, I
Theate, I
Stul, M
Scheiff, JM
Deneys, V
Ferrant, A
Hagemeijer, A
ANNALS OF HEMATOLOGY, 2004, 83 (09) : 578 - 583
[2] CD5-negative Blastoid Variant Mantle Cell Lymphoma with Complex CCND1/IGH and MYC Aberrations
Seok, Yoonmi
Kim, Juwon
Choi, Jong Rak
Kim, Yu Ri
Park, Seo-Jin
Kim, Sue Jung
Song, Jaewoo
Lee, Kyung-A
ANNALS OF LABORATORY MEDICINE, 2012, 32 (01) : 95 - 98
[3] Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma
Maekawa, Fumiyo
Kishimori, Chiyuki
Nakagawa, Miho
Takeoka, Kayo
Fukutsuka, Katsuhiro
Hayashida, Masahiko
Iioka, Futoshi
Fujimoto, Masakazu
Takeuchi, Kengo
Nakamine, Hirokazu
Ohno, Hitoshi
BLOOD ADVANCES, 2021, 5 (01) : 61 - 65
[4] SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?
Simonsen, Anita T.
Schou, Marie
Sorensen, Camilla D.
Bentzen, Hans H. N.
Nyvold, Charlotte G.
LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2724 - 2727
[5] Mantle cell lymphoma - blastoid variants associated to a particular CCND1 (Cyclin D1) probe set expression pattern.
Sander, B
Islam, T
Nygren, L
Kimby, EK
Lennartsson, P
Smith, CIE
Christensson, B
BLOOD, 2002, 100 (11) : 285B - 286B
[6] Blastoid Variant Mantle Cell Lymphoma with Amplified IGH/CCND1 Fusion: A Unique Case and Current Literature Review
Goktas, Emine
Sanal, Sumeyye
Esen, Haci Hasan
Tekinalp, Atakan
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2024, 62 (02): : 124 - 127
[7] Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies
Peterson, Jess F.
Baughn, Linda B.
Ketterling, Rhett P.
Pitel, Beth A.
Smoley, Stephanie A.
Vasmatzis, George
Smadbeck, James B.
Greipp, Patricia T.
Mangaonkar, Abhishek A.
Thompson, Carrie A.
Parikh, Sameer A.
Chen, Dong
Viswanatha, David S.
BLOOD ADVANCES, 2019, 3 (08) : 1298 - 1302
[8] REARRANGEMENT OF CCND1 (BCL1/PRAD1) 3' UNTRANSLATED REGION IN MANTLE-CELL LYMPHOMAS AND T(11Q13)-ASSOCIATED LEUKEMIAS
RIMOKH, R
BERGER, F
BASTARD, C
KLEIN, B
FRENCH, M
ARCHIMBAUD, E
ROUAULT, JP
LUCIA, BS
DURET, L
VUILLAUME, M
COIFFIER, B
BRYON, PA
MAGAUD, JP
BLOOD, 1994, 83 (12) : 3689 - 3696
[9] SOX11, CCND1, BCL1/Igh, and Igh-VDJ - a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?
Simonsen, Anita Tranberg
Schou, Marie
Sorensen, Camilla Darum
Hokland, Peter
Bentzen, Hans
Nyvold, Charlotte Guldborg
BLOOD, 2014, 124 (21)
[10] CD5-NEGATIVE MANTLE CELL LYMPHOMA WITH CCND1 AMPLIFICATION
Chalouhy, C.
Chalhoub, E.
Hammoud, D.
Bhagat, R.
Schmieg, J. J.
Levenson, B.
Safah, H.
Saba, N.
JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 375 - 375

← 1 2 3 4 5 →